Alejandro D. Ricart

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Patricia M. LoRusso, Weiwei Tan, K. Wilner, 2010, Clinical Cancer Research.